We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEPU
10151
Central Puerto
CEPU
$2.01B
$383K ﹤0.01%
149,640
+135,663
+971% +$307K
EAOK
10152
DELISTED
iShares ESG Aware Conservative Allocation ETF
EAOK
$383K ﹤0.01%
13,800
+2,862
+26% +$78.6K
PGRE
10153
PUT
DELISTED
Paramount Group
PGRE
$383K ﹤0.01%
38,000
+600
+2% +$6.38K
QUOT
10154
CALL
DELISTED
Quotient Technology Inc
QUOT
$383K ﹤0.01%
35,400
-12,600
-26% -$168K
STCN
10155
DELISTED
Steel Connect, Inc. Common Stock
STCN
$383K ﹤0.01%
20,541
+2,764
+16% +$51.6K
BIOR
10156
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$383K ﹤0.01%
+430
New +$329K
ADCT icon
10157
CALL
ADC Therapeutics
ADCT
$146M
$382K ﹤0.01%
15,700
+1,400
+10% +$32.5K
DRSK icon
10158
Aptus Defined Risk ETF
DRSK
$1.51B
$382K ﹤0.01%
12,887
EXTR icon
10159
Extreme Networks
EXTR
$2.95B
$382K ﹤0.01%
34,251
-85,397
-71% -$906K
LFUS icon
10160
CALL
Littelfuse
LFUS
$10.3B
$382K ﹤0.01%
1,500
-1,300
-46% -$339K
PIE icon
10161
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$255M
$382K ﹤0.01%
13,952
-56,749
-80% -$1.44M
VXUS icon
10162
Vanguard Total International Stock ETF
VXUS
$163B
$382K ﹤0.01%
5,815
-348,051
-98% -$22.8M
ALEX
10163
DELISTED
Alexander & Baldwin
ALEX
$381K ﹤0.01%
20,779
-4,932
-19% -$90.9K
JBGS
10164
PUT
JBG SMITH
JBGS
$708M
$381K ﹤0.01%
12,100
-11,300
-48% -$368K
LCTX icon
10165
CALL
Lineage Cell Therapeutics
LCTX
$281M
$381K ﹤0.01%
133,600
+118,200
+768% +$306K
SDIV icon
10166
Global X SuperDividend ETF
SDIV
$1.23B
$381K ﹤0.01%
+8,991
New +$384K
SGOL icon
10167
CALL
abrdn Physical Gold Shares ETF
SGOL
$7.45B
$381K ﹤0.01%
22,400
+10,300
+85% +$180K
VSH icon
10168
CALL
Vishay Intertechnology
VSH
$4.69B
$381K ﹤0.01%
+16,900
New +$405K
MODN
10169
DELISTED
MODEL N, INC.
MODN
$381K ﹤0.01%
11,130
+3,648
+49% +$134K
CVET
10170
CALL
DELISTED
Covetrus, Inc. Common Stock
CVET
$381K ﹤0.01%
14,100
-16,800
-54% -$470K
ASAN icon
10171
Asana
ASAN
$2.35B
$380K ﹤0.01%
6,121
-487,796
-99% -$18.8M
BITQ icon
10172
Bitwise Crypto Industry Innovators ETF
BITQ
$414M
$380K ﹤0.01%
+15,848
New +$358K
CAL icon
10173
Caleres
CAL
$419M
$380K ﹤0.01%
13,935
-39,947
-74% -$1M
FTFT icon
10174
PUT
Future FinTech Group
FTFT
$4.48M
$380K ﹤0.01%
151
+98
+185% +$280K
ACRE
10175
CALL
Ares Commercial Real Estate
ACRE
$258M
$379K ﹤0.01%
25,800
+4,900
+23% +$73.4K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.